Therefore, this study was undertaken to investigate the role of sitagliptin as an adjuvant therapy for early diabetic nephropathy in adolescents with type 1 diabetes on the AHCL system and to assess its relation to microalbuminuria, SDF-1, lipid profile and AHCL glucometrics. The gene discussed is CXCL12; the disease is diabetic kidney disease.